Literature DB >> 18246380

Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue.

Kosmas I Paraskevas.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18246380     DOI： 10.1007/s10067-008-0843-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.

Authors:  Koji Miyamoto; Kazuhiro Nishigami; Noritoshi Nagaya; Koichi Akutsu; Masaaki Chiku; Masataka Kamei; Toshihiro Soma; Shigeki Miyata; Masahiro Higashi; Ryoichi Tanaka; Takeshi Nakatani; Hiroshi Nonogi; Satoshi Takeshita
Journal:  Circulation       Date:  2006-12-04       Impact factor: 29.690

2.  Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease).

Authors:  J J Swigris; J W Olin; N A Mekhail
Journal:  J Vasc Surg       Date:  1999-05       Impact factor: 4.268

3.  A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease.

Authors:  A K Bozkurt; C Köksal; M Y Demirbas; A Erdoğan; A Rahman; U Demirkiliç; H Ustünsoy; G Metin; L Yillik; H Onol; B Cinar; M Karaçelik; I Erdinç; C Bolcal; A G Sayin
Journal:  Int Angiol       Date:  2006-06       Impact factor: 2.789

Review 4.  Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy.

Authors:  Kosmas I Paraskevas; Christos D Liapis; Despina D Briana; Dimitri P Mikhailidis
Journal:  Angiology       Date:  2007 Feb-Mar       Impact factor: 3.619

5.  Successful intravenous regional sympathetic blockade (Bier's Block) with guanethidine and lidocaine in a patient with advanced Buerger's Disease (thromboangiitis obliterans)--a case report.

Authors:  Kosmas I Paraskevas; Aikaterini A Trigka; Maria Samara
Journal:  Angiology       Date:  2005 Jul-Aug       Impact factor: 3.619

6.  Buerger's disease: a 10-year experience in Tehran, Iran.

Authors:  Hassan Tavakoli; Jalal Rezaii; Khalil Esfandiari; Javad Salimi; Armin Rashidi
Journal:  Clin Rheumatol       Date:  2008-01-03       Impact factor: 2.980

7.  Autologous bone marrow transplantation and hyperbaric oxygen therapy for patients with thromboangiitis obliterans.

Authors:  Shigeru Saito; Koichi Nishikawa; Hideaki Obata; Fumio Goto
Journal:  Angiology       Date:  2007-07-24       Impact factor: 3.619

8.  Clinical and social consequences of Buerger disease.

Authors:  Takashi Ohta; Hiroyuki Ishioashi; Minoru Hosaka; Ikuo Sugimoto
Journal:  J Vasc Surg       Date:  2004-01       Impact factor: 4.268

9.  Retroperitoneoscopic lumbar sympathectomy for buerger's disease: a novel technique.

Authors:  Jagdish Chander; Lakhvinder Singh; Pawan Lal; Akhilesh Jain; Pawanindra Lal; V K Ramteke
Journal:  JSLS       Date:  2004 Jul-Sep       Impact factor: 2.172
  9 in total
  2 in total

1.  Reply: "Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue".

Authors:  Hassan Tavakoli; Javad Salimi; Armin Rashidi
Journal:  Clin Rheumatol       Date:  2008-04-11       Impact factor: 2.980

2.  Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study.

Authors:  Gert Baumann; Verena Stangl; Peter Klein-Weigel; Karl Stangl; Michael Laule; Kathrin Enke-Melzer
Journal:  Clin Res Cardiol       Date:  2011-03-05       Impact factor: 5.460
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.